StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance PIRS opened at $0.18 on Friday. The stock has a market capitalization of $17.58 million, a price-to-earnings ratio of […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 3.1 % Shares of PIRS stock opened at $0.17 on Friday. Pieris Pharmaceuticals has a fifty-two week low of $0.14 and […]
Silverarc Capital Management LLC Acquires New Position in Pieris Pharmaceuticals, Inc (NASDAQ:PIRS) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 2.1 % NASDAQ PIRS opened at $0.20 on Thursday. The stock has a market capitalization of $19.42 million, a P/E ratio […]
Tucatinib Combo May Benefit Advanced HER2-Positive Breast Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.